Arcturus Therapeutics Holdings Inc. Logo

Arcturus Therapeutics Holdings Inc.

A commercial-stage mRNA medicines company focused on rare and infectious diseases.

ARCT | US

Overview

Corporate Details

ISIN(s):
US03969T1097
LEI:
Country:
United States of America
Address:
10628 SCIENCE CENTER DRIVE, 92121 SAN DIEGO

Description

Arcturus Therapeutics Holdings Inc. is a commercial-stage messenger RNA (mRNA) medicines company focused on the discovery, development, and commercialization of therapeutics and vaccines. The company's primary areas of interest are infectious diseases and rare diseases, with a particular emphasis on respiratory and liver conditions. Its development pipeline includes candidates for Ornithine Transcarbamylase (OTC) deficiency (ARCT-810) and Cystic Fibrosis (ARCT-032), as well as vaccine programs. Arcturus leverages its proprietary technologies, including the LUNAR® lipid-mediated nanoparticle delivery system and the STARR® self-amplifying mRNA platform, to advance its portfolio of RNA-based medicines.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2024-12-15
English
4.2 MB
2024-10-30
German
1.8 MB
2024-08-14
French
0.5 MB
2024-05-22
English
2.1 MB
2024-03-10
English
3.5 MB
2024-01-15
German
1.2 MB
2023-11-20
English
5.1 MB

Full Filing History Restricted

Access to specific historical documents or filtered results is limited in the Web UI. Request access to the complete dataset.

Automate Your Workflow. Get a real-time feed of all Arcturus Therapeutics Holdings Inc. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Arcturus Therapeutics Holdings Inc.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Arcturus Therapeutics Holdings Inc. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Biofrontera AG Logo
Biopharmaceutical firm specializing in photodynamic therapy for skin conditions.
Germany
B8F
Biofrontera Inc. Logo
A biopharmaceutical company commercializing products for dermatological conditions.
United States of America
BFRI
BioGaia Logo
A healthcare and biotechnology company developing clinically proven probiotic products.
Sweden
BIOG
BIOGEN INC. Logo
Biotechnology company developing therapies for neurological and neurodegenerative diseases.
United States of America
BIIB
Bio Green Med Solution, Inc. Logo
A diversified company in the biopharmaceutical and fire safety sectors.
United States of America
BGMS
BIOHARVEST SCIENCES INC. Logo
A biotech firm using a platform to grow plant cells for health and wellness products.
United States of America
BHST
Biohaven Ltd. Logo
Develops therapies for neuroscience, immunology, and oncology for unmet medical needs.
United States of America
BHVN
BioInvent International Logo
Develops novel, first-in-class immuno-modulatory antibodies for cancer therapy.
Sweden
BINV
BIOLIFE SOLUTIONS INC Logo
Manufactures biopreservation media and tools for cell and gene therapy markets.
United States of America
BLFS
BioLineRx Ltd. Logo
A clinical-stage biopharmaceutical company developing therapies for oncology and rare diseases.
Israel
BLRX

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.